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A Ab bs st tr ra ac ct t
In addition to a relatively small number of well known hereditary cancer syndromes, hundreds of presumed
or proven hereditary disorders have been observed to manifest cancer as a characteristic feature or as a
possible complication. The recognition of these disorders may be of great importance for the medical
management of the families involved. Specialized databases, like the Familial Cancer Database (FaCD,
www.facd.info), may be helpful in the making of differential diagnoses and offer advantages compared with
traditional textbooks and on-line literature searches. Based on our own experience and interviews with the
other Dutch family cancer clinics, we expect that in similar clinics, computer-assisted differential diagnosis will
be primarily used in helping to decide whether or not cancer patients and families should be referred to family
cancer clinics for further study and counseling. FaCD has been developed as a tool for experts. As general
practitioners and other health professionals with non-expert knowledge of cancer genetics are under increasing
pressure to advise on genetic risks, it should be encouraged that other software is developed to support them
in interpreting family histories of cancer. 
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In addition to a relatively small number of hereditary
cancer syndromes generally well known by physicians,
genetic nurses and counselors, hundreds of presumed or
proven hereditary disorders have been observed to
manifest cancer as a characteristic feature or possible
complication. The recognition of these disorders may be
of great importance for the medical management of the
families involved. Understandably, active knowledge on
the wide range of less frequent disorders is not as
common as that on the more frequent ones. Even some
of the health professionals specialized in the field of
clinical cancer genetics might find themselves hard
pressed to give details, from the top of their hat, on
disorders like familial clustering of multiple myeloma,
mesothelioma, salivary gland tumors or Sezary syndrome. 
Traditionally, textbooks and journal articles are used
to help with the making of differential diagnoses, and
several valuable textbooks on hereditary cancer have
been published [1-5]. These books tend to focus on the
more frequent and/or better known tumor syndromes,
but have the advantage of direct accessibility. Although
journal articles, in toto, cover a much wider range of
proven or presumed genetic disorders associated with
cancer or familial clusters of cancer, the ‘mining’ of these
articles by hand, or through on-line search engines like
PubMed (www.ncbi.nlm.nih.gov/entrez), while hunting
for a particular combination of tumors observed in a
patient/family may prove difficult and at least time-
consuming. 
On the other hand, a database developed with the
specific purpose in mind of offering a tool to assist with
the  making  of  a  differential  diagnosis,  has  the
advantage of covering a wide range of literature
sources, including older ones not yet available online,
as well as presenting a user interface specifically
designed to allow easy searching for combinations of
clinical features. In the field of clinical genetics, severalH He er re ed diit ta ar ry y  C Ca an nc ce er r  iin n  C Clliin niic ca all  P Pr ra ac ct tiic ce e 2003; 1(1) 32
of these databases have been developed [6], of which
the London Dysmorphology Database [7], POSSUM
[8] and the Human Cytogenetics Database [9] are the
most widely used ones in genetics clinics. A similar type
of database for cancer genetics did not exist until
recently when the Familial Cancer Database (FaCD)
was developed [10]. In the year 2000, the software
was first released, through the internet (www.facd.info),
in support of the Familial Cancer and Prevention
Program of the UICC (Union Internationale Contre le
Cancer,  International  Union  Against  Cancer,
www.uicc.org). 
Unlike  expert  systems,  FaCD  and  the  other
mentioned  computer  programs  do  not  diagnose
conditions, but have a prompting function instead,
reminding their users of diagnoses they may not have
considered. The software is aimed at users with a level
of expertise which enables them to translate the clinical
features observed in a patient and his or her family into
the correct terminology, distill from those the best
“search-handles“ [11; 12] (e.g. early-onset cancer rather
than common cancer with normal age at diagnosis)
(Figure  1),  interpret  the  output  (Figure  2),  retain
diagnoses of interest, and discard the others. In the case
of FaCD, the software is aimed at health professionals
working in family cancer clinics and other clinicians with
an active interest in, and knowledge of, hereditary cancer
predisposition. These include, in particular, genetic
counselors, clinical geneticists and medical and surgical
oncologists and, indeed, these are counted among the
most frequent registrants of FaCD, as shown in Table 1. 
The performance of FaCD and similar databases
should be evaluated by looking at the performance of
the user and the software together [13]. Until such
studies have been performed, the added value of these
databases  remain  undefined.  We  have  yet  to
systematically study the use physicians and genetic
counselors make of FaCD in clinical practice, and its
possible added value. We can, however, report on the
use of FaCD during the last 3 years in the Groningen
Family Cancer Clinic, part of the department of Clinical
Genetics of the Groningen University Hospital. On a
yearly basis, approximately 700 patients/families are
referred to this clinic for genetic counseling and testing
with respect to cancer. In addition, the clinic serves as a
center of expertise to 17 regional hospitals and the
regional family physicians, yearly handling one to two-
hundred of their questions by telephone or mail on the
possible genetic nature of (combinations) of cancer in
a patient/family, in addition to straightforward referrals.
The vast majority of referrals to our clinic are for
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T Ta ab bl le e   1 1. .   Medical Profession of Registered FaCD users. By November
2002, 1114 users from a total of 74 different countries had registered
their copy of FaCD through our web site
P Pr ro of fe es ss si io on n % %
Clinical Geneticist/Genetic Counselor 36
Medical Oncologist/Internist 12
Surgeon 6
Pathologist 4
Radiation Oncologist 4
Gastroenterologist 2
General Practitioner 2
Pediatrician 1
Gynaecologist 1
Other Clinical Specialty 11
Molecular Geneticist 9
Scientist, non-clinical 7
Other 18
F Fi ig g. .   1 1. .   S Sc cr re ee en ns sh ho ot t   o of f   a a   s se ea ar rc ch h   p pr ro of fi il le e, ,   a a   p pa ar rt ti ic cu ul la ar r   c co om mb bi in na at ti io on n   o of f   t tu um mo or r
a an nd d   n no on n- -t tu um mo or r   f fe ea at tu ur re es s, ,   e en nt te er re ed d   i in nt to o   F Fa aC CD D   b by y   t th he e   u us se er r. .   A Af ft te er r   s su ub bm mi it tt ti in ng g
t th he e   p pr ro of fi il le e, ,   F Fa aC CD D   w wi il ll l   r re et tu ur rn n   a a   l li is st t   o of f   a al ll l   o of f   i it ts s   s st to or re ed d   s sy yn nd dr ro om me es s   w wh hi ic ch h
f fe ea at tu ur re e   t th he e   i it te em ms s   e en nt te er re ed d   i in n   t th he e   s se ea ar rc ch h   p pr ro of fi il le e, ,   i in nc cl lu ud di in ng g   p pu ub bl li is sh he ed d   b bu ut t
a as s   y ye et t   u un np pr ro ov ve en n   a as ss so oc ci ia at ti io on ns s   i if f   t th he e   u us se er r   s so o   w wi is sh he es s. .   I In n   t th hi is s   e ex xa am mp pl le e, ,   t th he e
u us se er r   h ha as s   n ne ei it th he er r   s sp pe ec ci if fi ic cs s   o on n   t th he e   t ty yp pe e   o of f   t tu um mo or r   o of f   u ut te er ru us s   o or r   c ce er rv vi ix x   n no or r
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(suspected) hereditary breast-(ovarian) cancer (HBOC)
or hereditary non-polyposis colorectal cancer (HNPCC),
with a steady, but significantly smaller, number of referrals
for (suspected) familial adenomatous polyposis, multiple
endocrine neoplasia type 1 and 2, Von Hippel-Lindau
disease and other familial clustering of cancer or multiple
primary tumors. In our setting, FaCD is rarely used in the
many cases of suspected HBOC or HNPCC, because
these referrals usually have been made after meeting a
set of clinical criteria that warrant a high suspicion for
those particular (suspected) disorders and the differential
diagnosis in these cases is well known to our clinical
geneticists/genetic counselors. However, FaCD has
proven to be helpful in our work as consultants to the
regional hospitals and family physicians. A wide range
of cancer types observed to cluster in families is reported
to our clinic for advice, either by mail or by phone, and
FaCD lends support when deciding if referral to our clinic
is warranted. Although, in our clinic, FaCD is mainly
used in the step before possible referral, we regularly
use its encyclopedic function by consulting the clinical
summaries  of  the  syndromes  in  the  database  for
extended tumor spectrum and ‘facts and figures’ that
might come in handy during particular counseling
sessions. We have recently polled the other Dutch family
cancer clinics on their use of FaCD, which revealed that
they use the software in a similar way. FaCD has been
developed as a tool for experts rather than as an expert
system for use by general practitioners and other
physicians with limited knowledge of cancer genetics.
Increasingly, however, these non-experts in genetics are
under pressure to advise their patients on genetic risks,
including risks to develop cancer. Therefore, it is
important to encourage the development of software
to assist them in interpreting family histories of cancer
[14, 15].
A  new  version  of  FaCD  (2.0),  with  updated
database contents, improved user interface, optional
saving of the user’s search profiles and easy linking to
internet sources, is presently under construction and is
expected  to  be  released  through  the  internet
(www.facd.info) in 2003. User feed back is appreciated
(facd@medgen.azg.nl).
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F Fi ig g. .   2 2. .   Screenshot of differential diagnosis returned by FaCD after matching the search profile as seen in Figure 1 with its database contents